The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
D | Dermatologicals | |
2
|
D10 | Anti-acne preparations | |
3
|
D10A | Anti-acne preparations for topical use | |
4
|
D10AF | Antiinfectives for treatment of acne | |
5
|
D10AF01 | Clindamycin |
| Active Ingredient |
|---|
|
Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis. |
| Document | Type | Information Source | |
|---|---|---|---|
| DALACIN C Capsule | MPI, EU: SmPC | Medicines and Medical Devices Safety Authority (NZ) | |
| DALACIN CREAM Vaginal Cream | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| DALACIN T Topical solution | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) | |
| ZINDACLIN Gel | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.